Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima and Masaru Murai

Size: px
Start display at page:

Download "Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima and Masaru Murai"

Transcription

1 Assessment of Long-Term Quality of Life Using the FACT-BL Questionnaire in Patients with an Ileal Conduit, Continent Reservoir, or Orthotopic Neobladder Eiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima and Masaru Murai Department of Urology, Keio University School of Medicine, Tokyo, Japan Received May 16, 2006; accepted July 9, 2006; published online October 3, 2006 Objective: To assess and compare quality of life (QOL) of patients followed for a long time who underwent an ileal conduit (IC), continent reservoir (CR) or ileal neobladder (NB) using FACT-BL, a bladder-cancer-specific questionnaire. Methods: One hundred and forty-seven patients underwent radical cystectomy and urinary diversion for bladder cancer from 1987 to 2002 at our institution. Of them, 79 (54%) patients were asked to participate in this study. Forty-nine patients (20 IC, 14 CR and 15 NB) returned the answered questionnaire for a survey response rate of 62%. Mean follow-up was 83.0 months. Results: Four categories (physical, social/familial, emotional and functional well-being) in FACT-G were equally favorable in these groups. Patients with IC had less trouble controlling urine but had a worse image on altered body appearance compared with NB patients. Interest in sex was extremely low in all patients and capability of maintaining an erection was also low in 39 male patients. The mean total value of FACT-BL in IC, CR and NB patients was , , and , respectively, showing no significant difference. Ten (77%) of 13 IC, seven (78%) of nine CR and six (86%) of seven NB patients answered that they would choose the same type of diversion if they had the choice again. Conclusions: The type of urinary diversion does not appear to be associated with a different QOL by general cancer-related assessment. Urinary function and body image are affected and related to the method used to reconstruct the urinary system. Key words: quality of life total cystectomy urinary diversion Jpn J Clin Oncol 2006;36(11) doi: /jjco/hyl094 INTRODUCTION With the development of numerous techniques for continent reconstruction of the lower urinary tract, the trend has markedlychangedinthewayinwhichurologistsselectameans of urinary reconstruction as the most appropriate urinary diversion after radical cystectomy (1). During the 1980s the main urinary diversions were ileal conduits and continent cutaneous reservoirs, respectively. Since the early 1990s, orthotopic urinary reservoirs have been replacing those urinary diversions with acceptable morbidity rates (2). Meanwhile, it is of great importance to assess patients quality of life (QOL) to understand the psychological, physical and social consequences of urinary reconstruction. For reprints and all correspondence: Eiji Kikuchi, Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo , Japan; eiji-k@kb3.so-net.ne.jp However, the comparative impact of different types of urinary diversions on health related QOL has not been well studied. The re-evaluation of the patients QOL seems long overdue. Patients with bladder cancer have common problems as seen among any cancer patients. Once they undergo urinary reconstruction after cystectomy, they also have specific problems related to the surgery, such as urine leakage, change of body image and loss of sexual interest. Most previous studies, however, assessed QOL of bladder-cancer patients using the instruments available for general cancer patients (3, 4). As these questionnaires are sometimes with untested validity and reliability, it is difficult to assess the difference among the studies. FACT-BL, a bladder-cancer-specific module has recently become available for use in conjunction with FACT-G (5), which is intended for general cancer patients. Although these validated instruments are assumed # 2006 Foundation for Promotion of Cancer Research

2 Jpn J Clin Oncol 2006;36(11) 713 to be useful, few studies have compared the QOL of patients with an ileal conduit (IC), a continent cutaneous reservoir (CR), or an orthotopic neobladder (NB), using the FACT-BL questionnaire (6). In the present study, we assessed the QOL of patients followed for a long time who underwent different forms of urinary diversions, using Japanese version of the FACT-BL questionnaire. We examined differences in urinary diversionrelated symptoms, such as trouble controlling urine, body image dissatisfaction, and sexual dysfunction and dissatisfaction. PATIENTS AND METHODS 147 patients underwent radical cystectomy and urinary diversion for invasive bladder cancer from 1987 to 2002 at our institution. Potency-preserving surgery was not performed routinely. Of them, 42 (29%) patients were dead at the time of the present study, 24 (16%) were inaccessible by mail, one (0.6%) was too old to answer the questionnaire and one (0.6%) had undergone conversion from a cutaneous Kock pouch to an IC. Consequently, 79 (54%) patients were available for the assessment. Each patient was mailed a questionnaire packet, informed consent form, personal cover letter and a stamped return envelope. A total of 49 (62%) answered questionnaires were returned to us. These patients included 20 with an IC, 14 with a CR (Indiana pouch in five, Kock pouch in eight, and Mainz pouch in one), and 15 with a NB. Mean follow-up was 83.0 months (20 202). QOL was assessed using FACT-BL. The following scores were calculated from the FACT-BL questionnaire and list: physical well-being (PWB), social/family well-being (SWB), emotional well-being (EWB), functional well-being (FWB), total FACT-G, overall bladder-specific subscale and total FACT-BL score. A high FACT score indicated a high level of QOL. The questionnaire was translated into Japanese using an iterative forward back method (7). As for the bladder-specific subscale, because one question is only for men, and two questions are only for patients with an ostomy appliance, we did not include these results and the overall bladder-specific subscale score was calculated from the remaining nine questions of the 12 bladder-specific ones. The medical records of each patient were reviewed. Clinical parameters, including age, type of diversion, final pathological status and current disease status, were recorded. Statistical analyses were performed using the Mann Whitney U-test or one-way analysis of variance followed by Bonferroni s correction for continuous variables and Fisher s exact test or chi-square test for categorical variables. A P value less than 0.05 was considered to indicate statistical significance. RESULTS The comparison between respondents and non-respondents revealed no significant differences in the percent of males, or of patients with pathological stage T3 or greater (Table 1). Respondents were significantly younger than nonrespondents both at the time of surgery and survey. Respondents underwent IC less frequently than nonrespondents (41 versus 80%). Furthermore, the rate of no evidence of disease was higher and the follow-up period was longer in respondents. When respondents were stratified by type of diversion, no differences were found in the number of patients with pathological stage T3 or greater, number of patients administered chemotherapy, number of patients subjected to radiotherapy, number of disease-free patients and age at the time of the survey (Table 2). There were 13, 11 and 15 male patients with an IC, CR and NB, respectively (P ¼ 0.039). Patients Table 1. Comparison between survey respondents and non-respondents Respondents No. Pts (%) Non-respondents No. Pts (%) P value No. Pts Mean age at surgery + SD (years) No. men 39 (79.6%) 26 (86.7%) Mean follow-up + SD (months) No. pathological stage T3 or greater 13 (26.5%) 10 (33.3%) Type of diversion Ileal conduit 20 (40.8%) 24 (80.0%) Continent cutaneous reservoir 14 (28.6%) 4 (13.3%) Orthotopic neobladder 15 (30.6%) 2 (6.7%) No. disease-free 45 (91.8%) 20 (66.7%) Mean age at the survey + SD (years) Pts, patients; SD, standard deviation.

3 714 Long-term QOL after urinary diversion Table 2. Medical and demographic data of respondents distributed Ileal conduit Continent cutaneous reservoir Orthotopic neobladder No. Pts Mean age at surgery + SD (years) * No. men 13 (65%) 11 (78.6%) 15 (100%) Mean follow-up + SD (months) * No. pathological stage T3 or greater 5 (25.0%) 5 (35.7%) 3 (20%) No. systemic chemotherapy Neoadjuvant 1 (5%) 1 (7.1%) 0 (0%) Adjuvant 3 (15.0%) 3 (21.4%) 4 (26.7%) No. post-operative radiotherapy 1 (5%) 0 (0%) 1 (6.7%) No. disease-free 18 (90.0%) 14 (100%) 13 (86.7%) Mean age at the survey + SD (years) Pts, patients; SD, standard deviation. *P, 0.05 versus continent cutaneous diversion reservoir. P, 0.05 versus continent cutaneous reservoir and orthotopic neobladder. Table 3. Summary of FACT-BL in the diversion groups Function (maximum) Overall (mean + SD) Ileal conduit (mean + SD) Continent cutaneous reservoir (mean + SD) Orthotopic neobladder (mean + SD) PWB (28) SWB (28) EWB (24) FWB (28) FACT-G (108) Bladder-specific subscale (36) FACT-BL (144) SD, standard deviation; PWB, physical well-being; SWB, social/family well-being; EWB, emotional well-being; FWB, functional well-being; FACT-G, functional assessment of cancer therapy general; FACT-BL, functional assessment of cancer therapy bladder. with a CR were significantly younger than those with an IC (P ¼ 0.003). Patients with a CR were followed up significantly longer than those with an IC (P ¼ 0.023). FACT-BL scores are shown in Table 3. The overall mean + SD of FACT-G was of a total of 108 points. The patients had high scores for PWB. However, SWB scores were approximately half the maximum obtainable scores. The mean + SD of FACT-G in patients with an IC, CR, and NB was , and , respectively, showing no significant differences. Total scores of bladder-cancer subscale and FACT-BL were similar among the urinary diversion groups. The results of the bladder-cancer subscale questionnaire are shown in Table 4. Seventeen (85%) of 20 patients with an IC answered no trouble at all in controlling urine, compared to eight (57%) of 14 patients with a CR and three (20%) of 15 patients with a NB. Patients with an IC had significantly less trouble controlling urine than those with a NB (mean + SD of versus , P ¼ 0.018). However, half of the patients with an IC reported that they did not like the appearance of their bodies at all, compared with only one (7%) patient with a CR and two (13%) with a NB. Patients with an IC had a significantly worse QOL score regarding their body image than those with a NB (mean + SD of versus , P ¼ 0.036). There were no significant differences regarding the control of bowel function among the three diversion groups. Fifteen (75%) of 20, eight (57%) of 14, and eight (53%) of 15 patients with an IC, CR and NB, respectively, had interest in sex not at all. Twelve (92%) of 13, 11 (100%) of 11 and 11 (73%) of 15 patients with an IC, CR and NB respectively, reported inability to maintain an erection. The questions I am embarrassed by my ostomy appliance and Caring for my ostomy appliance is difficult were answered by some of the patients with an IC or a CR, while these two statements were only for patients with an ostomy appliance. There were no significant differences in QOL score for these two questions between the IC and CR groups.

4 Jpn J Clin Oncol 2006;36(11) 715 Table 4. Answer to each bladder-cancer subscale question Not at all A little bit Somewhat Quite a bit Very much I have trouble controlling my urine IC CR NB I like the appearance of my body IC CR NB I am interested in sex IC CR NB I am able to have and maintain an erection IC CR NB I am embarrassed by my ostomy appliance IC CR Caring for my ostomy is difficult IC CR IC, ileal conduit; CR, continent cutaneous reservoir; NB, orthotopic neobladder. Patients were also asked whether they would choose the same type of diversion if they had the choice again; 10 (77%) of 13 IC, seven (78%) of nine CR and six (86%) of seven NB patients answered they would choose the same diversion. DISCUSSION In the present study, we used the Japanese version of the FACT-BL, an accepted and well-known questionnaire to assess differences in QOL among patients with bladder cancer subjected to different types of urinary diversion. Dutta et al. used FACT-G in 72 patients with an IC or a NB and found no significant differences in total FACT-G score between the two groups (8). However, they noted that patients with a NB had a significantly better QOL than those with an IC in the areas of EWB and FWB. In contrast, we did not find any difference between the two groups in any of four domains of FACT-G. Mansson et al. compared the QOL of 64 patients with a CR or NB using FACT-BL and observed no differences in any domain of FACT-G between the two groups (6). In their study, patients with a CR had significantly less trouble controlling urine and patients with a NB had a significantly better appreciation of their body appearance. In our series, patients with a CR tended to have less trouble controlling urine (mean + SD of in CR group versus in NB group) and patients with a NB tended to have a better appreciation of their body appearance (mean + SD of inCRgroupversus in NB group). We found that our patients with an IC had significantly less trouble controlling urine than those with a NB, as reported by other authors (9, 10). Better stoma appliances and post-operative care by a skilled stoma therapist might have reduced the stoma related problems. Some degree of urinary leakage, especially at night, is a constant finding in NB patients (11). However, it is considered that patients in our population were adapted to and accepted their urinary diversion. Patients with an IC may come to manage their diversion well over time and this situation may make urine control more easily manageable and their QOL may then be comparable to that of those with a CR and a NB. In our study the score for external body image in patients with an IC was the poorest among the three groups and patients with a CR had a slightly poorer body image than those with a NB, as reported in other studies (9, 12). Although patients with a CR do not need an external appliance, they still have a stoma, which may affect the perception of their body image. The effect of surgery on sexual function depends largely on the extent of the operation. Radical cystectomy without nerve sparing surgery almost inevitably results in impotence. Furthermore, loss of interest in sex was thought to be based on having a stoma and older age. However, we found a reduced sexual capacity in the great majority of patients without nerve sparing surgery, with no difference being noted among the IC, CR and NB groups. Hart et al. reported that patients had a low QOL score in sexual function regardless of the type of urinary diversion and recipients who had a penile prosthesis placed had a significantly better sexual function and satisfaction (13). It might be necessary for

5 716 Long-term QOL after urinary diversion physicians to counsel and discuss the availability of erectile aids and phosphodiesterase-5 inhibitor therapy to improve the sexual life of patients who undergo radical cystectomy. The present study has some limitations. First of all, it was retrospective and non-randomized. The decision to perform any type of urinary diversion depends upon many considerations, including patient and surgeon preferences, co-morbidity and patient s age and body build. In most series, patients receiving an IC tend to be older. In our series of 147 patients, the mean age + SD of 86 patients who underwent IC was years old, which was significantly older compared to the 36 who underwent CR ( ) or the 24 subjected to NB ( ). In some situations, the surgeon might have tended to select IC for patients with more co-morbidities to perform urinary diversion in a shorter operative time. However, as there were no differences in pathological stage, grade of bladder cancer, lymph node status in radical cystectomy specimens and cause-specific survival rate among the three diversion groups (data not shown), there seemed to be no selection bias as IC was performed on patients with more advanced disease. Comparison between respondents and non-respondents demonstrated that 45% of the 44 patients with an IC responded our questionnaire, compared to 78% of the 18 patients with a CR and 88% of the 17 patients with a NB. It is possible that patients with an IC who did not participate might have been more dissatisfied with the outcome of surgery than participants or might have felt more uncomfortable. There were no differences in the number of patients with pathological stage T3 or greater and G3. However, respondents were younger at surgery and at the time of the survey and had been followed up for longer periods than non-respondents. Furthermore, there were significant differences in the number of disease-free patients. These differences might have influenced our QOL results. Further large and prospective longitudinal research will be needed to clarify the real differences among these three diversion groups. CONCLUSION Despite the limitations as a result of the small sample size and type of survey, our study demonstrates that the type of urinary diversion does not appear to be associated with differential post-operative QOL. In contrast, urinary function and body image are affected and related to the method used to reconstruct the urinary system. Reduced sexual satisfaction and capacity was frequently encountered in our study population. Acknowledgments This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. References 1. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19: Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. JUrol2003;169: Kitamura H, Miyao N, Yanase M, Masumori N, Matsukawa M, Takahashi A, et al. Quality of life in patients having an ileal conduit, continent reservoir or orthotopic neobladder after cystectomy for bladder carcinoma. Int J Urol 1999;6: Hobisch A, Tosun K, Kinzl J, Kemmler G, Bartsch G, Holtl L, et al. Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversio. Semin Urol Oncol 2001;19: Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11: Mansson A, Davidsson T, Hunt S, Mansson W. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int 2002;90: Hinotsu A, Niimi M, Akaza H, Miyanaga N, Takeshima H, Eremenco S, et al. Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: pilot study (in Japanese). Gan To Kagaku Ryoho 1999;26: Dutta SC, Chang SC, Coffey CS, Smith JA, Jr., Jack G, Cookson MS. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. JUrol2002;168: Bjerre BD, Johansen C, Steven K. Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol 1995;75: Sullivan LD, Chow VD, Ko DS, Wright JE, McLoughlin MG. An evaluation of quality of life in patients with continent urinary diversions after cystectomy. Br J Urol 1998;81: Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol 2000;18: Bjerre BD, Johansen C, Steven K. Health-related quality of life after urinary diversion: continent diversion with the Kock pouch compared with ileal conduit. A questionnaire study. Scand J Urol Nephrol 1994;157(Suppl): Hart S, Skinner EC, Meyerowitz BE, Boyd S, Lieskovsky G, Skinner DG. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol 1999;162:77 81.

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer

The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer Hiroki Ide, Eiji Kikuchi, Akira Miyajima, Ken Nakagawa, Takashi Ohigashi, Jun Nakashima and Mototsugu

More information

Body Image Following Radical Cystectomy and Ileal Neobladder or Conduit in Korean Patients

Body Image Following Radical Cystectomy and Ileal Neobladder or Conduit in Korean Patients www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.3.161 Original Article - Urological Oncology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.3.161&domain=pdf&date_stamp=2014-03-17

More information

The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?

The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? Blackwell Science, LtdOxford, UK BJUBJU International1464-4096BJU International 90 2899 QOL AFTER RADICAL CYSTECTOMY AND BLADDER SUBSTITUTION Å. MÅNSSON et al. 10.1046/j.1464-4096.2002.02899.x Original

More information

URINARY DIVERSIONS. Winter 2016 Dr P. O Malley

URINARY DIVERSIONS. Winter 2016 Dr P. O Malley URINARY DIVERSIONS Winter 2016 Dr P. O Malley OVERVIEW Who gets diversions? What s involved with cystectomy? What are the different types of diversions? What are the problems with various diversions? How

More information

Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study

Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study Original Article Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study M. A. Asgari, M. R. Safarinejad 1, N. Shakhssalim

More information

Cystectomies and bladder preservation: What you need to know

Cystectomies and bladder preservation: What you need to know Cystectomies and bladder preservation: What you need to know Robin Morash RN, BNSc, MHS Bladder Cancer Canada November 21, 2018 Presentation goals Review the options for treatment of muscle-invasive bladder

More information

Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder

Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder Jpn J Clin Oncol 2002;32(1)14 18 Optimal Timing of Radical Cystectomy for Patients with Invasive Transitional Cell Carcinoma of the Bladder Isao Hara, Hideaki Miyake, Shoji Hara, Akinobu Gotoh, Hiroshi

More information

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto

Koji Ichihara Hiroshi Kitamura Naoya Masumori Fumimasa Fukuta Taiji Tsukamoto Int J Clin Oncol (2013) 18:75 80 DOI 10.1007/s10147-011-0346-8 ORIGINAL ARTICLE Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in

More information

Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey

Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey 758 Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey MINGYING YANG 1,2*, HAIFENG WANG 2*, JIANSONG WANG 2 and MINGHUI RUAN 1

More information

Bladder replacement in men and women: when and when not? Outline. Continent Diversion History

Bladder replacement in men and women: when and when not? Outline. Continent Diversion History 1 Bladder replacement in men and women: when and when not? Eila C. Skinner, MD Professor of Clinical Urology Keck USC School of Medicine Outline 1) Selection criteria for orthotopic diversion: Tumor-related

More information

The Clinical Impact of the Classification of Carcinoma In Situ on Tumor Recurrence and their Clinical Course in Patients with Bladder Tumor

The Clinical Impact of the Classification of Carcinoma In Situ on Tumor Recurrence and their Clinical Course in Patients with Bladder Tumor Original Article Japanese Journal of Clinical Oncology Advance Access published December 17, 2010 Jpn J Clin Oncol 2010 doi:10.1093/jjco/hyq228 The Clinical Impact of the Classification of Carcinoma In

More information

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors ORIGINAL ARTICLE Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors Chen-Hsun Ho, 1,2 Chao-Yuan Huang, 1 Wei-Chou Lin, 3 Shih-Chieh Chueh, 1 Yeong-Shiau

More information

Radical Cystectomy A Patient s Guide

Radical Cystectomy A Patient s Guide Radical Cystectomy A Patient s Guide Introduction The urinary system, which includes the bladder, urethra, ureters, and kidneys, helps maintain stable chemical conditions in the body, stores, and eliminates

More information

Radical Cystectomy Often Too Late? Yes, But...

Radical Cystectomy Often Too Late? Yes, But... european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer

More information

TCC recurrence within the upper tract urothelium following

TCC recurrence within the upper tract urothelium following Upper Tract Urothelial Recurrence Following Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: An Analysis of 1,069 Patients With 10-Year Followup Kristin M. Sanderson,* Jie Cai, Gustavo

More information

Partial Cystectomy for Invasive Bladder Cancer

Partial Cystectomy for Invasive Bladder Cancer European Urology Supplements European Urology Supplements 4 (2005) 67 71 Partial Cystectomy for Invasive Bladder Cancer Gerald H. Mickisch* Center of Operative Urology Bremen, Academic Hospital Bremen

More information

Recovery of sexual function after radical cystectomy with orthotopic neobladder

Recovery of sexual function after radical cystectomy with orthotopic neobladder Recovery of sexual function after radical cystectomy with orthotopic neobladder C. Gingu, V. Olaru, A. Dick, C. Baston, M. Crăsneanu, C. Surcel, S. Voinea, Liliana Domnişor, I. Sinescu Center of Urological

More information

Health-Related Quality-of-Life Following Modified Ureterosigmoidostomy (Mainz Pouch II) as Continent Urinary Diversion

Health-Related Quality-of-Life Following Modified Ureterosigmoidostomy (Mainz Pouch II) as Continent Urinary Diversion European Urology European Urology 46 (2004) 591 597 Health-Related Quality-of-Life Following Modified Ureterosigmoidostomy (Mainz Pouch II) as Continent Urinary Diversion Patrick J. Bastian a,*, Peter

More information

A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma Demonstrating the Usefulness of the Concept of Lymph Node Density

A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma Demonstrating the Usefulness of the Concept of Lymph Node Density Clinical Urology TCC of the Bladder and Lymph Node Density International Braz J Urol Vol. 32 (5): 536-549, September - October, 2006 A Fourteen-Year Review of Radical Cystectomy for Transitional Cell Carcinoma

More information

Point/Counterpoint: Quality of Life Considerations for Patients with Muscle Invasive Bladder Cancer Pro Trimodality Therapy

Point/Counterpoint: Quality of Life Considerations for Patients with Muscle Invasive Bladder Cancer Pro Trimodality Therapy Point/Counterpoint: Quality of Life Considerations for Patients with Muscle Invasive Bladder Cancer Pro Trimodality Therapy Kimberley S. Mak, MD, MPH Assistant Professor Boston Medical Center Boston University

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Outcome of Open Radical Cystectomy and Ileal Conduit: A Single Center Experience Mahesh Kalloli

More information

Long-Term Complications of Conduit Urinary Diversion

Long-Term Complications of Conduit Urinary Diversion Long-Term Complications of Conduit Urinary Diversion Mark S. Shimko,* Matthew K. Tollefson, Eric C. Umbreit, Sara A. Farmer, Michael L. Blute and Igor Frank From the Department of Urology (MSS, MKT, ECU,

More information

BCAN Fall Series: Survivorship

BCAN Fall Series: Survivorship BCAN Fall Series: Survivorship The New Normal after Bladder Removal and Urinary Diversion Vashti Livingston RN, MS, CNS, CWOCN Ambulatory Urology MSKCC NYC livingsv@mskcc.org Disclosure None BCAN Volunteer

More information

Clinical Outcomes of Patients with pt0 Bladder Cancer after Radical Cystectomy: A Single-institute Experience

Clinical Outcomes of Patients with pt0 Bladder Cancer after Radical Cystectomy: A Single-institute Experience Clinical Outcomes of Patients with pt0 Bladder Cancer after Radical Cystectomy: A Single-institute Experience Fumimasa Fukuta, Naoya Masumori *, Ichiya Honma, Masatoshi Muto, Koji Ichihara, Hiroshi Kitamura

More information

URINARY DIVERSIONS. Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania

URINARY DIVERSIONS. Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania URINARY DIVERSIONS Susan Hilton, MD and Nicholas Papanicolaou, MD Co-Chiefs, CT Section Hospital of the University of Pennsylvania Neither of us has any financial relationships with commercial interests

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy

A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy ORIGINAL ARTICLE Vol. 42 (4): 663-670, July - August, 2016 doi: 10.1590/S1677-5538.IBJU.2015.0393 A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing

More information

Efficacy of Bladder-Preserving Therapy for Patients with T3b, T4a, and T4b Transitional Cell Carcinoma of the Bladder

Efficacy of Bladder-Preserving Therapy for Patients with T3b, T4a, and T4b Transitional Cell Carcinoma of the Bladder www.kjurology.org DOI:10.4111/kju.2010.51.8.525 Urological Oncology Efficacy of Bladder-Preserving Therapy for Patients with T3b, T4a, and T4b Transitional Cell Carcinoma of the Bladder Jaewoo Cheon, Hyunchul

More information

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy

Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Jpn J Clin Oncol 2002;32(11)461 465 Clinical Study of G3 Superficial Bladder Cancer without Concomitant CIS Treated with Conservative Therapy Takashi Saika, Tomoyasu Tsushima, Yasutomo Nasu, Ryoji Arata,

More information

Early radical cystectomy in NMIBC Marko Babjuk

Early radical cystectomy in NMIBC Marko Babjuk Early radical cystectomy in NMIBC Marko Babjuk Dept. of Urology, 2nd Faculty of Medicine, Hospital Motol, Praha, Czech Republic We Are The European Association of Urology We Are Urologists, residents,

More information

Review Article Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship

Review Article Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship Advances in Urology Volume 2012, Article ID 142135, 10 pages doi:10.1155/2012/142135 Review Article Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship N. E. Mohamed, 1 M. A. Diefenbach, 1 H.

More information

Lymph node dissection: how much is enough?

Lymph node dissection: how much is enough? 1 Background Lymph node dissection: how much is enough? Eila C. Skinner, MD Professor of Clinical Urology USC Keck School of Medicine Radical cystectomy is the gold standard for the treatment of invasive

More information

YASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI KADONO, HIROYUKI KONAKA, ATSUSHI MIZOKAMI and MIKIO NAMIKI

YASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI KADONO, HIROYUKI KONAKA, ATSUSHI MIZOKAMI and MIKIO NAMIKI Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer YASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI

More information

Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent Pouch with Abdominal Stoma

Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent Pouch with Abdominal Stoma Case Report Urol Int 1999;62:213 216 Received: June 19, 1998 Accepted after revision: March 8, 1999 Urethral Carcinoma Recurrence in Ileal Orthotopic Neobladder: Urethrectomy and Conversion in a Continent

More information

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008 Chemotherapy and Bladder Cancer Blayne Welk UBC Urology Grand Rounds June 4, 2008 Outline Review of Incidence and Impact of bladder cancer Neoadjuvant chemotherapy Adjuvant chemotherapy Bladder preservation

More information

Comparison of Three Types of Continent Urinary Diversions in a Single Center

Comparison of Three Types of Continent Urinary Diversions in a Single Center Article TheScientificWorldJOURNAL (2004) 4 (S1), 135 141 ISSN 1537-744X; DOI 10.1100/tsw.2004.59 Comparison of Three Types of Continent Urinary Diversions in a Single Center Cengiz Girgin, M.D., Akif Sezer,

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title:Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic

More information

Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report)

Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report) Microscopic Study of Histological Changes the Use of Ileal Mucosa as a Bladder (Radical Cystectomy - Case Report) Sareh Najaf Asaadi, Hassan Morovvati, Ahmad Reza Taftachi International Journal of Advanced

More information

QoL AFTER URINARY DIVERSION

QoL AFTER URINARY DIVERSION . JOURNAL COMPILATION 2008 BJU INTERNATIONAL Miscellaneous URINARY DIVERSION: EVIDENCE-BASED OUTCOMES AND DECISION-MAKING LEE and LATINI BJUI BJU INTERNATIONAL Urinary diversion: evidence-based outcomes

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

The outcome of non-muscle invasive urinary bladder tumour at Makassed General Hospital

The outcome of non-muscle invasive urinary bladder tumour at Makassed General Hospital Makassed General Hospital The outcome of non-muscle invasive urinary bladder tumour at Makassed General Hospital Imad El Hajjar Department of surgery, Urology division Introduction Most common malignancy

More information

OUTCOME OF ORTHOTOPIC NEOBLADDER AFTER RADICAL CYSTECTOMY

OUTCOME OF ORTHOTOPIC NEOBLADDER AFTER RADICAL CYSTECTOMY OUTCOME OF ORTHOTOPIC NEOBLADDER AFTER RADICAL CYSTECTOMY MA SALAM, MS ISLAM, MM UDDIN, MM SHAFIQUR, S HASAN, P SAHA, KR ABEDIN, GM MAULA Abstract Objective: To assess the results of patients underwent

More information

Impact of Self-Care Instructional Program on Urostomy Patients' Outcome

Impact of Self-Care Instructional Program on Urostomy Patients' Outcome Med. J. Cairo Univ., Vol. 82, No. 1, December: 839-848, 2014 www.medicaljournalofcairouniversity.net Impact of Self-Care Instructional Program on Urostomy Patients' Outcome NAGWA M.A. MOHAMED, D.N.Sc.

More information

Evaluation of prognostic factors after radical prostatectomy in pt3b prostate cancer patients in Japanese population

Evaluation of prognostic factors after radical prostatectomy in pt3b prostate cancer patients in Japanese population Japanese Journal of Clinical Oncology, 2015, 45(8) 780 784 doi: 10.1093/jjco/hyv077 Advance Access Publication Date: 15 May 2015 Original Article Original Article Evaluation of prognostic factors after

More information

Trimodality Therapy for Muscle Invasive Bladder Cancer

Trimodality Therapy for Muscle Invasive Bladder Cancer Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,

More information

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy.

Influence of stage discrepancy on outcome in. in patients treated with radical cystectomy. Tumori, 96: 699-703, 2010 Influence of stage discrepancy on outcome in patients treated with radical cystectomy Ja Hyeon Ku 1, Kyung Chul Moon 2, Cheol Kwak 1, and Hyeon Hoe Kim 1 1 Department of Urology,

More information

Questions & Answers about Sexuality and Intimacy after Bladder Cancer. Part III: Causes and Treatments for Sexual Dysfunction

Questions & Answers about Sexuality and Intimacy after Bladder Cancer. Part III: Causes and Treatments for Sexual Dysfunction Questions & Answers about Sexuality and Intimacy after Bladder Cancer A Valentine's chat with Dr. Trinity Bivalacqua Monday, February 13, 2017 Part III: Causes and Treatments for Sexual Dysfunction Presented

More information

Bladder Preservation Strategies for Muscle Invasive Bladder Cancer

Bladder Preservation Strategies for Muscle Invasive Bladder Cancer Bladder Preservation Strategies for Muscle Invasive Bladder Cancer Jeff M. Michalski, MD, MBA, FACR, FASTRO The Carlos A. Perez Distinguished Professor of Radiation Oncology Department of Radiation Oncology

More information

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression Kobayashi et al. BMC Urology 2014, 14:5 RESEARCH ARTICLE Open Access Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening

More information

Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate

Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate European Urology European Urology 43 (2003) 646 650 Sexuality Preserving Cystectomy and Neobladder (SPCN): Functional Results of a Neobladder Anastomosed to the Prostate W. Meinhardt *, S. Horenblas Department

More information

Highlighting Clinical Trials Muscle Invasive Bladder Cancer

Highlighting Clinical Trials Muscle Invasive Bladder Cancer Highlighting Clinical Trials Muscle Invasive Bladder Cancer Part I: The Basics of MIBC Clinical Trials June 19, 2018 Presented by: Dr. Peter Black is a urologic oncologist at Vancouver General Hospital,

More information

RUNNING HEAD: BLADDER CANCER and SEXUAL FUNCTION

RUNNING HEAD: BLADDER CANCER and SEXUAL FUNCTION Sexual Functioning after Diagnosis and/or Treatment of Bladder Cancer: a Systematic Review Bachelor thesis Department of Medical Psychology, Tilburg University Author: Manon van Eekelen Supervisor: Dr.

More information

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by

Part II: Treatment. A Woman-to-Woman Talk with Dr. Armine Smith. Wednesday, March 8, Presented by Women & Bladder Cancer A Woman-to-Woman Talk with Dr. Armine Smith Wednesday, March 8, 2017 Part II: Treatment Presented by Dr. Smith is an Assistant Professor of Urology at Johns Hopkins University and

More information

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016 BLADDER CANCER = UROTHELIAL CANCER Antiquated term is Transitional Cell Carcinoma

More information

Gynecologic-Tract Sparing Extra Peritoneal Retrograde Radical Cystectomy with Neobladder

Gynecologic-Tract Sparing Extra Peritoneal Retrograde Radical Cystectomy with Neobladder Clinical Urology Gynecologic-Tract Sparing Radical Cystectomy International Braz J Urol Vol. 34 (2): 180-190, March - April, 2008 Gynecologic-Tract Sparing Extra Peritoneal Retrograde Radical Cystectomy

More information

ROBOTIC VS OPEN RADICAL CYSTECTOMY

ROBOTIC VS OPEN RADICAL CYSTECTOMY ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to

More information

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology

More information

Muscle-invasive bladder cancer

Muscle-invasive bladder cancer Patient Information English 4 Muscle-invasive bladder cancer The underlined terms are listed in the glossary. What is muscle-invasive bladder cancer? About a quarter of patients diagnosed with bladder

More information

1. Introduction. 2. Methods. high-risk NMIBC in men with and without a prior history of RT for PC.

1. Introduction. 2. Methods. high-risk NMIBC in men with and without a prior history of RT for PC. ISRN Urology Volume 2013, Article ID 405064, 5 pages http://dx.doi.org/10.1155/2013/405064 Research Article Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in

More information

NEOADJUVANT ENDOCRINE THERAPY PRIOR TO NERVE-SPARING

NEOADJUVANT ENDOCRINE THERAPY PRIOR TO NERVE-SPARING NEOADJUVANT ENDOCRINE THERAPY PRIOR TO NERVE-SPARING RADICAL PROSTATECTOMY IN PATIENTS WITH STAGE T2 PROSTATIC CANCER Takeshi Uedal, Hiroomi Nakatsul, Shigeo Isaka2 and Jun Shimazaki2 1Urology, Kumagaya

More information

Ileal orthotopic neo-bladder (IOB): how Quality of Life (QoL) of recipients can be measured. M.Niero (Dept of Education University of Verona ITA)

Ileal orthotopic neo-bladder (IOB): how Quality of Life (QoL) of recipients can be measured. M.Niero (Dept of Education University of Verona ITA) Ileal orthotopic neo-bladder (IOB): how Quality of Life (QoL) of recipients can be measured S.Siracusano (Dip.of Urology University of Trieste ITA) M.Niero (Dept of Education University of Verona ITA)

More information

Clinical Significance of Bacteriuria in Patients with Orthotopic Sigmoid Neobladder after Radical Cystectomy

Clinical Significance of Bacteriuria in Patients with Orthotopic Sigmoid Neobladder after Radical Cystectomy African Journal of Urology 1110-5704 Vol. 15, No. 4, 2009 233-237 Original Article Clinical Significance of Bacteriuria in Patients with Orthotopic Sigmoid Neobladder after Radical Cystectomy INTRODUCTION

More information

Bowel Function Remains Subjectively Unchanged After Ileal Resection for Construction of Continent Ileal Reservoirs

Bowel Function Remains Subjectively Unchanged After Ileal Resection for Construction of Continent Ileal Reservoirs EUROPEAN UROLOGY 60 (2011) 585 590 available at www.sciencedirect.com journal homepage: www.europeanurology.com Reconstructive Urology Bowel Function Remains Subjectively Unchanged After Ileal Resection

More information

INVASIVE BLADDER CANCER

INVASIVE BLADDER CANCER INVASIVE BLADDER CANCER - Aspects on staging and prognosis Liedberg, Fredrik 2006 Link to publication Citation for published version (APA): Liedberg, F. (2006). INVASIVE BLADDER CANCER - Aspects on staging

More information

Department of Urology, Cochin hospital Paris Descartes University

Department of Urology, Cochin hospital Paris Descartes University Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate

More information

Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy

Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy Japanese Journal of Clinical Oncology, 2015, 45(10) 963 967 doi: 10.1093/jjco/hyv098 Advance Access Publication Date: 29 July 2015 Original Article Original Article Impact of adjuvant chemotherapy on patients

More information

Predictors of use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: Data from a pilot study of 2414 cases

Predictors of use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: Data from a pilot study of 2414 cases Predictors of use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: Data from a pilot study of 2414 cases 2004-2010 Luke Hounsome 1, Gary Abel 2, Julia Verne 1, David Neal

More information

Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience

Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience DOI 10.1186/s40064-015-1200-7 RESEARCH Open Access Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10 year, single center experience Nozomi Hayakawa 1,2*, Nobuyuki Kikuno 1,2, Hiroki

More information

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Jeffrey M. Holzbeierlein, MD, FACS John W Weigel Professor & Chair Director of Urologic Oncology University of Kansas

More information

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer

Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer Clinical Commissioning Policy Proposition: Robotic Assisted Surgery for Bladder Cancer Reference: NHS England B14X08 Information Reader Box (IRB) to be inserted on inside front cover for documents of 6

More information

Policy #: 370 Latest Review Date: April 2017

Policy #: 370 Latest Review Date: April 2017 Name of Policy: Nerve Graft with Radical Prostatectomy Policy #: 370 Latest Review Date: April 2017 Category: Surgery Policy Grade: B Background/Definitions: As a general rule, benefits are payable under

More information

Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients

Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients Original Article : oncologic outcome in 271 Chinese patients Zhi-Ling Zhang, Pei Dong, Yong-Hong Li, Zhuo-Wei Liu, Kai Yao, Hui Han, Zi-Ke Qin and Fang-Jian Zhou Abstract Few large scale studies have reported

More information

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer

More information

Introduction. Teck Wei Tan 1,2 Rajesh Nair 1 Sanad Saad 1 Ramesh Thurairaja 1 Muhammad Shamim Khan 1

Introduction. Teck Wei Tan 1,2 Rajesh Nair 1 Sanad Saad 1 Ramesh Thurairaja 1 Muhammad Shamim Khan 1 World Journal of Urology (2019) 37:367 372 https://doi.org/10.1007/s00345-018-2386-4 ORIGINAL ARTICLE Safe transition from extracorporeal to intracorporeal urinary diversion following robot assisted cystectomy:

More information

REVIEW. Patterns of recurrence of bladder carcinoma following radical cystectomy

REVIEW. Patterns of recurrence of bladder carcinoma following radical cystectomy Cancer Imaging (2003) 3, 96 100 DOI: 10.1102/1470-7330.2003.0009 CI REVIEW Patterns of recurrence of bladder carcinoma following radical cystectomy D M Koh and J E Husband Academic Department of Radiology,

More information

CHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre

CHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre CHEMO-RADIOTHERAPY FOR BLADDER CANCER Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre AIMS Muscle invasive disease Current Gold-Standard Rationale behind Chemo-Radiotherapy

More information

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate Dr. Tareq Salah Ahmed,MD,ESMO Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate 1 st Assiut Urology department conference,marsa Alam 3 rd February 2015 Bladder cancer

More information

How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy?

How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? Japanese Journal of Clinical Oncology, 2015, 45(4) 373 377 doi: 10.1093/jjco/hyv001 Advance Access Publication Date: 30 January 2015 Original Article Original Article How does visceral obesity affect surgical

More information

Abstract. Background. About the authors. Purpose. CONJ RCSIO Fall/Automne

Abstract. Background. About the authors. Purpose. CONJ RCSIO Fall/Automne Radical cystectomy for bladder cancer: A qualitative study of patient experiences and implications for practice by Margaret I. Fitch, Debbie Miller, Sharon Sharir and Alison McAndrew Abstract Patients

More information

Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature

Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature european urology 50 (2006) 1176 1182 available at www.sciencedirect.com journal homepage: www.europeanurology.com Review Bladder Cancer Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic

More information

Haijun Zhou, Jae Y Ro, Luan D Truong, Alberto G Ayala, Steven S Shen

Haijun Zhou, Jae Y Ro, Luan D Truong, Alberto G Ayala, Steven S Shen Am J Clin Exp Urol 2014;2(2):156-160 www.ajceu.us /ISSN:2330-1910/AJCEU0000048 Original Article Intraoperative frozen section evaluation of ureteral and urethral margins: studies of 203 consecutive radical

More information

10th anniversary of 1st validated CaPspecific

10th anniversary of 1st validated CaPspecific Quality of Life after Treatment of Localised Prostate Cancer Dr Jeremy Grummet Clinical Uro-Oncology Fellow May 28, 2008 1 Why? This is important May be viewed as soft science Until we know which treatment

More information

Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer

Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer Original Article Japanese Journal of Clinical Oncology Advance Access published October 22, 2009 Jpn J Clin Oncol 2009 doi:10.1093/jjco/hyp126 Docetaxel in Combination with Prednisolone for Hormone Refractory

More information

When to Integrate Surgery for Metatstatic Urothelial Cancers

When to Integrate Surgery for Metatstatic Urothelial Cancers When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male

More information

Abstract. Original Article

Abstract. Original Article Original Article Middle East Journal of Cancer; July 2015; 6(3): 165-170 A Comparison of Early Results and Patient Satisfaction Rate between Modified Radical Cystectomy with Mainz II Urinary Diversion

More information

INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER

INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER & INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER Mustafa Hiroš *, Hajrudin Spahović, Mirsad Selimović, Sabina Sadović Urology Clinic, University of Sarajevo

More information

Orthotopic neobladder reconstruction what are the options?

Orthotopic neobladder reconstruction what are the options? Minirev Article ORTHOTOPIC NEOBLADDER RECONSTRUCTION MEYER et al. Orthotopic neobladder reconstruction what are the options? JON-PAUL MEYER, DEREK FAWCETT*, DAVID GILLATT and RAJENDRA PERSAD Department

More information

3.1 Investigations for Patients Presenting with Haematuria Table 1

3.1 Investigations for Patients Presenting with Haematuria Table 1 3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

MEDitorial March Bladder Cancer

MEDitorial March Bladder Cancer MEDitorial March 2010 Bladder Cancer Last month, my article addressed the issue of blood in the urine ( hematuria ). A concerning cause of hematuria is bladder cancer, a variably malignant tumor starting

More information

Chapter 1: General Introduction and Outline of the Thesis

Chapter 1: General Introduction and Outline of the Thesis Chapter 1: General Introduction and Outline of the Thesis General Introduction and Outline of the Thesis Introduction In the Netherlands radical cystectomy is the gold standard treatment for therapy resistant

More information

Extraperitoneal Approach Induces Postoperative Inguinal Hernia Compared with Transperitoneal Approach after Laparoscopic Radical Prostatectomy

Extraperitoneal Approach Induces Postoperative Inguinal Hernia Compared with Transperitoneal Approach after Laparoscopic Radical Prostatectomy Original Article Japanese Journal of Clinical Oncology Advance Access published December 22, 2009 Jpn J Clin Oncol 2009 doi:10.1093/jjco/hyp172 Extraperitoneal Approach Induces Postoperative Inguinal Hernia

More information

RADICAL PROSTATECTOMY AND QUALITY OF LIFE AMONG AFRICAN AMERICANS

RADICAL PROSTATECTOMY AND QUALITY OF LIFE AMONG AFRICAN AMERICANS RADICAL PROSTATECTOMY AND QUALITY OF LIFE AMONG AFRICAN AMERICANS Prostate-specific antigen screening has led to an increase in the number of men who present with localized prostate cancer. Patients must

More information

BJUI. 35% had lymph node involvement at radical cystectomy or subsequent recurrence within the dissection template.

BJUI. 35% had lymph node involvement at radical cystectomy or subsequent recurrence within the dissection template. 2010 THE AUTHORS; 2010 Urological Oncology LYMPH NODE STATUS IN PT0 BLADDER CANCER KAAG ET AL. BJUI Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical

More information

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy for Bladder Cancer

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy for Bladder Cancer Clinical Urology Bladder Cancer Staging International Braz J Urol Vol. 33 (1): 25-32, January - February, 2007 Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy

More information

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer Original Article Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer Sunai Leewansangtong, Suchai Soontrapa, Chaiyong Nualyong, Sittiporn Srinualnad, Tawatchai Taweemonkongsap and Teerapon

More information

Running head: Treatment modality and long term renal function in MIBC-Hamidi et al.

Running head: Treatment modality and long term renal function in MIBC-Hamidi et al. Running head: Treatment modality and long term renal function in MIBC-Hamidi et al. Effect of Treatment Modality on Long Term Renal Functions in Patients With Muscle Invasive Bladder Cancer Nurullah Hamidi

More information

Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience

Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience International Scholarly Research Notices, Article ID 702653, 6 pages http://dx.doi.org/10.1155/2014/702653 Research Article Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer

More information